BIOCRYST PHARMACEUTICALS INC (BCRX)

US09058V1035 - Common Stock

4.135  -0.08 (-1.78%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
331.41M270.80M157.20M17.80M48.80M
Cost Of Goods
4.66M6.60M7.30M1.70M4.10M
Gross Profit
326.75M264.20M149.90M16.10M44.70M
Operating Expenses
428.91M412.70M327.60M190.90M144.20M
Research and Development
215.02M253.30M208.80M123.00M107.10M
Selling, General, and Administrative Expenses
213.89M159.40M118.80M67.90M37.10M
Operating Income
-102.16M-148.40M-177.70M-174.80M-99.50M
Interest Income/Expense
-93.50M-95.90M-59.90M-6.00M-9.40M
Non Recurring Items
-30.57M0.0055.80M-2.00MN/A
Income Before Taxes
-226.23M-244.40M-181.80M-182.80M-108.90M
Income Tax
310.00K2.70M2.30MN/AN/A
Net Income
-226.54M-247.10M-184.10M-182.80M-108.90M
EBITDA
-100.51M-146.96M-176.92M-174.05M-98.78M
 
Per Share Data
EPS Diluted Total Ops
-1.18-1.33-1.03-1.09-0.94
Non GAAP EPS
-0.99-1.33-1.03-1.08-0.98
 
Statistics
Gross Profit Margin
98.59%97.56%95.36%90.45%91.60%
Profit Margin
-68.36%-91.25%-117.11%-1026.97%-223.16%
Operating Profit Margin
-30.83%-54.80%-113.04%-982.02%-203.89%

All data in USD

Charts